Kanika Watson, Director of Public Affairs at the U.S. Food and Drug Administration, discusses the rapid migration to digital as a result of COVID-19 and how it has transformed how organizations engage with the public. She shares a case study on the FDA's overnight pivot to 100% virtual stakeholder engagement and outreach. She also covers some best practices and shares what's next for agency public engagement post-pandemic.